AWM Investment Company’s LeMaitre Vascular LMAT Stock Holding History

AWM Investment Company’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-62,000	Closed	-$5.03M	–	108
2025 Q4	$5.03M	Hold	62,000	–	–	0.49%	60
2025 Q3	$5.43M	Sell	62,000 -68,000	-52%	-$6.07M	0.51%	55
2025 Q2	$10.8M	Sell	130,000 -15,000	-10%	-$1.25M	1.21%	30
2025 Q1	$12.2M	Sell	145,000 -5,000	-3%	-$465K	1.68%	24
2024 Q4	$13.8M	Sell	150,000 -15,000	-9%	-$1.44M	1.68%	26
2024 Q3	$15.3M	Sell	165,000 -35,000	-18%	-$3.03M	1.86%	11
2024 Q2	$16.5M	Sell	200,000 -7,000	-3%	-$514K	2.22%	8
2024 Q1	$13.7M	Sell	207,000 -23,000	-10%	-$1.42M	1.8%	16
2023 Q4	$13.1M	Hold	230,000	–	–	1.72%	19
2023 Q3	$12.5M	Hold	230,000	–	–	1.85%	16
2023 Q2	$15.5M	Hold	230,000	–	–	2.1%	13
2023 Q1	$11.8M	Hold	230,000	–	–	1.6%	20
2022 Q4	$10.6M	Hold	230,000	–	–	1.53%	23
2022 Q3	$11.7M	Hold	230,000	–	–	1.77%	15
2022 Q2	$10.5M	Hold	230,000	–	–	1.65%	20
2022 Q1	$10.7M	Hold	230,000	–	–	1.38%	24
2021 Q4	$11.6M	Hold	230,000	–	–	1.16%	25
2021 Q3	$12.2M	Hold	230,000	–	–	1.2%	27
2021 Q2	$14M	Hold	230,000	–	–	1.39%	25
2021 Q1	$11.2M	Hold	230,000	–	–	1.25%	29
2020 Q4	$9.31M	Hold	230,000	–	–	1.18%	32
2020 Q3	$7.48M	Hold	230,000	–	–	1.23%	30
2020 Q2	$6.07M	Hold	230,000	–	–	1.06%	37
2020 Q1	$5.73M	Sell	230,000 -85,000	-27%	-$2.63M	1.52%	25
2019 Q4	$11.3M	Hold	315,000	–	–	2.21%	17
2019 Q3	$10.8M	Hold	315,000	–	–	2.28%	14
2019 Q2	$8.81M	Sell	315,000 -15,000	-5%	-$417K	1.69%	20
2019 Q1	$10.2M	Hold	330,000	–	–	2.01%	17
2018 Q4	$7.8M	Hold	330,000	–	–	1.7%	20
2018 Q3	$12.8M	Sell	330,000 -20,194	-6%	-$728K	2.11%	13
2018 Q2	$11.7M	Sell	350,194 -3,600	-1%	-$128K	1.96%	19
2018 Q1	$12.8M	Sell	353,794 -150,000	-30%	-$5.2M	2.47%	13
2017 Q4	$16M	Sell	503,794 -57,974	-10%	-$1.99M	3.11%	7
2017 Q3	$21M	Sell	561,768 -102,660	-15%	-$3.49M	3.67%	7
2017 Q2	$20.7M	Sell	664,428 -100,677	-13%	-$2.91M	3.67%	6
2017 Q1	$18.8M	Hold	765,105	–	–	3.52%	5
2016 Q4	$19.4M	Sell	765,105 -71,509	-9%	-$1.59M	3.8%	3
2016 Q3	$16.6M	Sell	836,614 -132,146	-14%	-$2.31M	3.04%	7
2016 Q2	$13.8M	Sell	968,760 -90,000	-9%	-$1.38M	2.95%	8
2016 Q1	$16.4M	Sell	1,058,760 -132,757	-11%	-$1.9M	3.45%	5
2015 Q4	$20.6M	Hold	1,191,517	–	–	4.04%	5
2015 Q3	$14.5M	Sell	1,191,517 -138,341	-10%	-$1.77M	2.81%	8
2015 Q2	$16M	Hold	1,329,858	–	–	2.28%	9
2015 Q1	$11.1M	Hold	1,329,858	–	–	1.54%	17
2014 Q4	$10.2M	Buy	+1,329,858	New	+$9.52M	1.39%	20

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AWM Investment Company's LMAT Position: Q1 2026 in Review

AWM Investment Company sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 62,000 shares — an estimated $5.03M sold.

AWM Investment Company first reported a position in LMAT in Q4 2014 and held it in 45 quarters. The position peaked at $21M in Q3 2017. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

AWM Investment Company reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
AWM Investment Company sold 62,000 LeMaitre Vascular shares in Q1 2026, an estimated $5.03M.
AWM Investment Company first reported a position in LeMaitre Vascular in Q4 2014 and held it in 45 quarters.
AWM Investment Company's LeMaitre Vascular position peaked at $21M in Q3 2017.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.